Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-051-6 | CAS number: 91-22-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Biotransformation and kinetics
Administrative data
- Endpoint:
- biotransformation and kinetics
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- no data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No guideline available for this kind of study however, the study is well described and is scientifically valid.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- UPTAKE AND BIOTRANSFORMATION OF QUINOLINE BY RAINBOW TROUT
- Author:
- Bean RG, Dauble DD, Thomas BL, Hanf RW, Chess EK
- Year:
- 1 985
- Bibliographic source:
- Aquatic toxicology 7: 221-239
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The experiments were designed to determine the distribution and fate of quinoline within freshwater fish. Of further interest was to investigate biotransformation pathways through characterization of metabolites accumulated in various tissues. Rainbow trout were exposed to subacute levels of quinoline in defined water systems, and tissue concentrations were analyzed by capillary gas chromatography using a nitrogen/phosphorous detector or by gas chromatography/mass spectrometry.
- GLP compliance:
- not specified
- Type of medium:
- aquatic
Test material
- Reference substance name:
- Quinoline
- EC Number:
- 202-051-6
- EC Name:
- Quinoline
- Cas Number:
- 91-22-5
- Molecular formula:
- C9H7N
- IUPAC Name:
- quinoline
- Details on test material:
- [14C]Quinoline, uniformly labeled in the benzo ring, was synthesized and was purified (> 99%) by liquid chromatography. Specific activity was 7.6 µCi/µM. Quinoline standard (>99%) was obtained from Aldrich.
Constituent 1
Results and discussion
- Transformation products:
- yes
Any other information on results incl. tables
Table 1 : Estimates of the uptake and elimination rate constants and bioconcentration factors of quinoline plus metabolites (total radioactivity) and parent compound alone. Determinations based on whole body extracts of juvenile rainbow trout, mean weight. All values mean ± standard error
Compound |
Uptake rate constant (K1) |
Elimination rate constant (K2) |
Bioconcentration factor |
||
Based on uptake |
Based on elimination |
Based on uptake |
Based on elimination |
||
Quinoline metabolites |
0.58 ± 0.13 h-1 |
0.073 ± 0.022 h-1 |
0.074 ± 0.024 h-1 |
7.89 ± 0.82 |
7.78 ± 1.77 |
Quinoline |
1.02 ± 0.54 h-1 |
0.27 ± 0.16 h-1 |
-a |
3.73 ± 0.43 |
-a |
aElimination rate constant for quinoline was not calculated. All fish collected after 1 h in clean water contained less than detectable levels of quinoline.
Table 2 : Mean and range concentrations of parent compound and primary metabolites in selected tissues of juvenile rainbow trout. The 24-h and 48-h sample periods represent duration of exposure to 1.0 ± 0.1 mg/L quinoline in water and the 72-h sample period is after 24-h depuration. Concentrations are given as µg/g tissue.
Sample size (n) ranged from 3 to 6 for each time period.
Tissue |
24h |
48 h |
72 h |
|||||||||
|
1 |
2 |
3 |
4 |
1 |
2 |
3 |
4 |
1 |
2 |
3 |
4 |
Gallbladder and bile |
54 (7-66) |
70 (41-94) |
280 (130-480) |
23 (0-69) |
70 (22-140) |
140 (5-290) |
360 (130-730) |
110 (0-340) |
17 (1-44) |
100 (40-180) |
220 (92-340) |
230 (9-880) |
Liver |
1.4 (1.0-2.0) |
0.7 (0-1.3) |
1.6 (0.4-2.7) |
13 (8-23) |
1.4 (0.6-2.4) |
0.1 (0-0.3) |
0.3 (0-0.3) |
23 (6-47) |
ND |
0.9 (0.3-1.5) |
0.8 (0-1.4) |
1.9 (1.3-3.5) |
Kidney |
3.4 (2.0-4.4) |
0.1 |
ND |
4.7 (2.8-7.1) |
0.9 (0.1-2.0) |
ND |
ND |
3.6 (2.6-4.6) |
0.3 (0-0.4) |
0.1 |
ND |
1.1 (0.2-2.6) |
Muscle |
0.6 (0.3-1.7) |
ND |
ND |
0.5 (0-1.9) |
0.7 (0.2-1.8) |
<0.1 |
<0.1 |
0.2 (0.0-0.8) |
<0.1 |
<0.1 |
<0.1 |
0.3 (0.1-0.9) |
Gut |
4.4 (1.0-7.8) |
0.4 (0.2-0.7) |
0.8 (0.3-1.8) |
3.7 (0-11) |
3.2 (0.5-8.0) |
0.3 (0-0.9) |
0.5 (0-1.7) |
4.3 (2.0-7.3) |
0.1 (0-0.2) |
0.3 (0.1-0.7) |
0.2 (0-0.3) |
1.2 (0.5-2.9) |
Gill |
1.0 (0.2-2.2) |
<0.1 |
<0.1 |
1.4 (0.9-2.2) |
0.9 (0.8-1.0) |
<0.1 |
ND |
1.0 (0.7-1.6) |
<0.1 |
<0.1 |
<0.1 |
0.4 (0.2-0.8) |
Eye |
6.3 (3.9-9.5) |
<0.1 |
ND |
2.8 (1.5-5.4) |
4.5 (0.6-9.6) |
ND |
ND |
0.9 (0-2.8) |
0.6 (0.2-1.6) |
ND |
ND |
0.4 (0-0.9) |
1 = quinoline
2 = hydroxyquinoline
3 = quinolinethiol
4 = unidentified
ND = not detected
Applicant's summary and conclusion
- Executive summary:
Rainbow trout readily absorb and metabolize [14C]quinoline when exposed to 1 mg/l concentration in water. Juvenile fish accumulated over 60% of the total radiolabel body burden in the gall bladder as quinoline metabolites after 48 h exposure followed by 24 h in clean water. Hydrolysis products of the metabolites, isolated by alkaline digestion and base-catalysed acetylation, were found to be hydroxyquinolines and quinolinethiols. There is evidence that the hydroxy form was present in the gallbladders as the glucuronide was obtained from thin layer chromatographic experiments, and by cleavage with beta-glucuronidase The thiol, identified by high and low resolution mass spectrometry, predominated over the hydroxy derivative in most tissues examined. Relative body burdens of quinoline plus metabolites alter 48 h were in the order gallbladder > muscle > gut > eyes > liver similar to gill similar to kidney.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.